Qual é o preço para SD BioSensor, Inc (137310)

O preço para SD BioSensor, Inc (137310) é $4.23

Qual é a capitalização de mercado para SD BioSensor, Inc (137310)

A capitalização de mercado para SD BioSensor, Inc (137310) é $506.22M

SD BioSensor, Inc (137310) LPA

SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.

Ano	EPS	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

EPS

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	EPS	Diferença de EPS	País
Intuitive Surgical, Inc. ISRG.US	$8.85	-	US
EssilorLuxottica S.A. EL.PA	$6.41	-	FR
HOYA Corporation 7741.T	-	-	JP
Becton, Dickinson and Company BDX.US	$3.32	-	US
Alcon Inc. ALC.SW	-	-	CH

Empresa

EPS

Diferença de EPS

País